Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.65
2.48 %
$ 264 M
Market Cap
165.0
P/E
IRWD - COST OF REVENUE
Cost of Revenue IRWD - Ironwood Pharmaceuticals, Inc.
105 M
LAST VALUE
729.47%
2 YEAR CAGR
26.19%
5 YEAR CAGR
30.70%
10 YEAR CAGR